September 2026
1. ZHANG X, Wen T, Chen P, Chen S, et al
   CD19 CAR-macrophage suppressed the progression of DLBCL via modulating SYK/SHP2/TBK1/TFEB signaling.
   Biochem Biophys Res Commun. 2026;832:154378.
   

   >> Share

   
   August 2026
2. TODO K, Hikida M
   B cell receptor signaling promotes endogenous retrovirus-associated lymphomagenesis in T-cell-deficient B6-Ly5.1 mice.
   Biochem Biophys Res Commun. 2026;828:154139.
   

   >> Share

   
   
3. CHEN S, He Z, Ha Y
   PIP4K2A depletion suppresses AKT signaling and enhances chemotherapy sensitivity in T-cell lymphoblastic lymphoma cells.
   Biochem Biophys Res Commun. 2026;832:154404.
   

   >> Share

   
   May 2026
4. YU L, Wu S, Li L, Yang J, et al
   BCL2L10 Is a non-GCB-associated prognostic biomarker and functional driver in diffuse large B-Cell lymphoma.
   Biochem Biophys Res Commun. 2026;827:154000.
   

   >> Share

   
   January 2026
5. INOUE Y, Shimura Y, Niiyama-Uchibori Y, Chinen S, et al
   Multistep molecular trajectory of monocytic myeloid-derived suppressor cell induction by diffuse large B-cell lymphoma cells.
   Biochem Biophys Res Commun. 2026;804:153287.
   

   >> Share

   
   April 2025
6. FAUZI YR, Nakahata S, Shimoda K, Matsuura T, et al
   Anti-transferrin receptor antibody (JST-TFR09/PPMX-T003) induces ferroptosis in adult T-cell leukemia/lymphoma (ATLL) cells.
   Biochem Biophys Res Commun. 2025;756:151564.
   

   >> Share

   
   October 2023
7. YANG H, Liu Y, Yang J, Zhang Q, et al
   Upregulation of USP25 promotes progression of human diffuse large B-cell lymphoma through blocking the ubiquitinated degradation of MDM2.
   Biochem Biophys Res Commun. 2023;676:21-29.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share